Hyponatremia in cirrhosis is a common clinical dilemma, particular in those with profound portal hypertension. Excellent case base review by Juan Carlos Q Velez below

So lucky to have Ani Kardashian, M.D. USC Division of GI & Liver studying and advocating for equity in the treatment of liver disease!

Acute-on-chronic liver failure (ACLF) is a morbid diagnosis that carries high risk of short-term mortality. This Perspective describes a framework to guide the difficult conversations regarding initiating RRT to ease distress for all parties involved bit.ly/KID0382

Great tips on minimizing the stigma associated with AUD while establishing a therapeutic relationship with the patient

👋 #LiverTwitter! Heading to #DDW2024 and don't know where to start? We have curated a guide of hepato-centric and career building sessions that you should not miss!👇 #GItwitter #MedEd AASLD AASLD President American Gastroenterological Association (AGA)

We are doing a disservice to our patients with ALD when < 20% admitted patients receive pharmacotherapy for AUD on discharge. Rx for AUD therapy should be in the wheelhouse of gastroenterologists and hepatologists alike

In addition to all the important leadership skills the program imparts, it provides such an amazing opportunity to meet and network with like-minded peers and develop relationships that sustain far beyond the weekend. Carl Kay, MD Joseph Sleiman, MD, FACP Michelle Baliss, DO Alan L. Hutchison, MD, PhD (he/him)

Another generation of fine military gastroenterologist from SAUSHEC Gastroenterology & Hepatology ! Congrats!

Curious about serious illness communication (SIC) in cirrhosis care? Nneka N. Ufere, MD MSCE Shilpa Junna Dr. Keren Ladin and I explore barriers and solutions to SIC in our recently published Gastro Hep Advances narrative review below: ghadvances.org/article/S2772-… #palliativehepatology #livertwitter

Congrats to our tx hepatology graduates. #exceptional #toomanyaccoladestocount #goodhumans #alwayshustling This group was “consistent persistent and willing to work for it” ~TB Howard D Lee Divya ayyala Melanie Hundt USC Division of GI & Liver USC Liver Transplant jeffrey kahn Norah Terrault

🚨🚨GI/hep fellows studying for boards!🚨🚨🚨 ⬇️76 hepatology practice questions now available thanks to AASLD & Liver Fellow Network aasld.org/liver-fellow-n… 👏 👏👏Major kudos to fellow authors & faculty editor Matt Odenwald! #livertwitter #gitwitter #meded

One of the most challenging aspects of txp hep for me is the difficult conversations with pts and their families, particularly after the decision to decline for listing. Please join the panel & me below in navigating this important aspect of liver care! aasld.zoom.us/meeting/regist…

AUD is a chronic disease and alcohol relapse after transplant for ALD is unfortunately common. Amazing work from my previous co-fellow Divya ayyala and PD Helen Hyosun Han, MD USC Division of GI & Liver in looking at how we can serve this patient population!

Register ahead of time. Only two days left to register! aasld.zoom.us/meeting/regist… Liver Fellow Network #livertwitter #transplant

Great conversation with GI #livertwitter program directors with Liver Fellow Network! 🔹There is no "perfect" GI candidate 🔹GI is competitive--you have to be interested in medicine & clinically 🦾 🔹If you don't directly apply from residency, Why?"

Another amazing opportunity presented by Liver Fellow Network . I can attest to Divya ayyala being a selfless, amazing mentor hoping to improve trainee education!

😳20% of ALI w/ therapeutic doses ALI w/ therapeutic doses all coincided w/ excess 🍷or fasting ➡️worse prognosis (need to incorporate fasting pattern into my hx taking) If ALI patients are jaundiced- EtOH is involved #TLM24 LiverTox AASLD Credit- Dr. Alexander Louvet

📢 It’s OVER. The “lean MASLD paradox”? Just bad measurement. ❎MASLD with overweight BMI weren’t healthier! We were using the wrong metric. ↗️Waist circumference-related indices show a dose-dependent mortality risk across 3 prospective cohorts. Let’s reframe how we assess